Zoledronic Acid Injection, Solution, Concentrate
Product Images NDC 55111-685

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zoledronic Acid (NDC 55111-685). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

Zoledronic Acid Injection 4 mg/5 mL (0.8 mg/mL) concentrate for intravenous infusion in a 5 mL single-dose vial. The label states it is a sterile concentrate that is not for direct injection and must be diluted before use. Manufactured by Dr. Reddy's Laboratories Limited. The label includes NDC 55111-685-07, a barcode, storage instructions, and dosing preparation information.*

FDA Label Image

Graph (Graph)

A bar chart comparing the proportion of complete responders by day 10 in pooled HCM studies between Zoledronic Acid Injection 4 mg (n=86) and Pamidronate 90 mg (n=99). The y-axis shows percentage of complete responders, with Zoledronic Acid achieving approximately 85% and Pamidronate around 65%. A p-value of 0.002 is indicated above the bars, supporting statistical significance.*

FDA Label Image

Structure (Structure)

Chemical structure of zoledronic acid showing its molecular arrangement including the imidazole ring and two phosphonic acid groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.